Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment

New research suggests the bacteria that cause tuberculosis alter their metabolism to combat exposure to antimicrobials, and that these metabolic 'escape pathways' might be neutralized by new drugs to shorten the troublesome duration of therapy.